Detalhe da pesquisa
1.
Current management and perspectives for HCV recurrence after liver transplantation.
Liver Int
; 33 Suppl 1: 56-62, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23286847
2.
Practical management of boceprevir and immunosuppressive therapy in liver transplant recipients with hepatitis C virus recurrence.
Antimicrob Agents Chemother
; 56(11): 5728-34, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22908172
3.
Therapy with boceprevir or telaprevir in HIV/hepatitis C virus co-infected patients to treat recurrence of hepatitis C virus infection after liver transplantation.
AIDS
; 29(1): 53-8, 2015 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-25387314
4.
Multicenter Experience with Boceprevir or Telaprevir to Treat Hepatitis C Recurrence after Liver Transplantation: When Present Becomes Past, What Lessons for Future?
PLoS One
; 10(9): e0138091, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26394142
5.
Successful anti-hepatitis C virus therapy with telaprevir in an HIV/hepatitis C virus co-infected patient with a severe recurrence of hepatitis C virus infection on the liver graft.
AIDS
; 27(16): 2655-7, 2013 Oct 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-23939241